Literature DB >> 29773594

Interleukin-22 levels are increased in gastrointestinal graft-versus-host disease in children.

Dana T Lounder1, Pooja Khandelwal2, Nicholas J Gloude2, Christopher E Dandoy2, Sonata Jodele2, Mario Medvedovic3, Lee A Denson4, Adam Lane2, Kelly Lake2, Bridget Litts2, Alyss Wilkey2, Stella M Davies2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29773594      PMCID： PMC6165817          DOI： 10.3324/haematol.2017.174771

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R.

Authors:  M H Xie; S Aggarwal; W H Ho; J Foster; Z Zhang; J Stinson; W I Wood; A D Goddard; A L Gurney
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

2.  Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.

Authors:  Akira Andoh; Zhuobin Zhang; Osamu Inatomi; Sanae Fujino; Yasuyuki Deguchi; Yoshio Araki; Tomoyuki Tsujikawa; Katsuyuki Kitoh; Shokei Kim-Mitsuyama; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoshihide Fujiyama
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

3.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

4.  IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.

Authors:  J C Martin; G Bériou; M Heslan; C Bossard; A Jarry; A Abidi; P Hulin; S Ménoret; R Thinard; I Anegon; C Jacqueline; B Lardeux; F Halary; J-C Renauld; A Bourreille; R Josien
Journal:  Mucosal Immunol       Date:  2015-09-02       Impact factor: 7.313

5.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Emiko Mizoguchi; Yasuyo Shimomura; Akira Andoh; Atul K Bhan; Richard S Blumberg; Ramnik J Xavier; Atsushi Mizoguchi
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

Authors:  Alan M Hanash; Jarrod A Dudakov; Guoqiang Hua; Margaret H O'Connor; Lauren F Young; Natalie V Singer; Mallory L West; Robert R Jenq; Amanda M Holland; Lucy W Kappel; Arnab Ghosh; Jennifer J Tsai; Uttam K Rao; Nury L Yim; Odette M Smith; Enrico Velardi; Elena B Hawryluk; George F Murphy; Chen Liu; Lynette A Fouser; Richard Kolesnick; Bruce R Blazar; Marcel R M van den Brink
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745

7.  REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum.

Authors:  L M P Loonen; E H Stolte; M T J Jaklofsky; M Meijerink; J Dekker; P van Baarlen; J M Wells
Journal:  Mucosal Immunol       Date:  2013-12-18       Impact factor: 7.313

8.  IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis.

Authors:  Carlene L Zindl; Jen-Feng Lai; Yun Kyung Lee; Craig L Maynard; Stacey N Harbour; Wenjun Ouyang; David D Chaplin; Casey T Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-18       Impact factor: 11.205

9.  A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease.

Authors:  Penelope Pelczar; Mario Witkowski; Laura Garcia Perez; Jan Kempski; Anna G Hammel; Leonie Brockmann; Dörte Kleinschmidt; Sandra Wende; Cathleen Haueis; Tanja Bedke; Marco Witkowski; Susanne Krasemann; Stefan Steurer; Carmen J Booth; Philipp Busch; Alexandra König; Ursula Rauch; Daniel Benten; Jakob R Izbicki; Thomas Rösch; Ansgar W Lohse; Till Strowig; Nicola Gagliani; Richard A Flavell; Samuel Huber
Journal:  Science       Date:  2016-10-21       Impact factor: 63.714

10.  Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22.

Authors:  Hiroaki Takatori; Yuka Kanno; Wendy T Watford; Cristina M Tato; Greta Weiss; Ivaylo I Ivanov; Dan R Littman; John J O'Shea
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307
View more
  6 in total

1.  Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.

Authors:  Sharareh Siamakpour-Reihani; Felicia Cao; Jing Lyu; Yi Ren; Andrew B Nixon; Jichun Xie; Amy T Bush; Mark D Starr; James R Bain; Michael J Muehlbauer; Olga Ilkayeva; Virginia Byers Kraus; Janet L Huebner; Nelson J Chao; Anthony D Sung
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

Review 2.  The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease.

Authors:  Jarosław Biliński; Marcin Jasiński; Grzegorz W Basak
Journal:  Biomedicines       Date:  2022-04-01

3.  Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation.

Authors:  Sakhila Ghimire; Katharina U Ederer; Elisabeth Meedt; Daniela Weber; Carina Matos; Andreas Hiergeist; Florian Zeman; Daniel Wolff; Matthias Edinger; Hendrik Poeck; Wolfgang Herr; André Gessner; Ernst Holler; Sigrid Bülow
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 4.  Microbiota modification in hematology: still at the bench or ready for the bedside?

Authors:  Christopher J Severyn; Ryan Brewster; Tessa M Andermann
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 5.  Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.

Authors:  Qingxiao Song; Ubaydah Nasri; Defu Zeng
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

Review 6.  Microbiota modification in hematology: still at the bench or ready for the bedside?

Authors:  Christopher J Severyn; Ryan Brewster; Tessa M Andermann
Journal:  Blood Adv       Date:  2019-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.